These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 17593511)

  • 21. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
    Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective analysis of long-term lipid apheresis at a single center.
    Koziolek MJ; Hennig U; Zapf A; Bramlage C; Grupp C; Armstrong VW; Strutz F; Müller GA
    Ther Apher Dial; 2010 Apr; 14(2):143-52. PubMed ID: 20438535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic apheresis in idiopathic nephrotic syndrome].
    Moriconi L
    G Ital Nefrol; 2012; 29 Suppl 54():S67-72. PubMed ID: 22388834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The clinical efficacy of plasmapheresis in the combined therapy of patients with chronic glomerulonephritis and nephrotic syndrome].
    Kolesnik NA; Dudar' IA; Velichko MB
    Urol Nefrol (Mosk); 1993; (6):44-6. PubMed ID: 8160322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function.
    Muso E; Sakai S; Ogura Y; Yukawa S; Nishizawa Y; Yorioka N; Saito T; Mune M; Sugiyama S; Iino Y; Hirano T; Hattori M; Watanabe T; Yokoyama H; Sato H; Uchida S; Wada T; Shoji T; Oda H; Mori K; Kimura H; Ito O; Nishiyama A; Maruyama S; Inagi R; Fujimoto S; Tsukamoto T; Suzuki Y; Honda H; Babazono T; Tsuruya K; Yuzawa Y
    Ther Apher Dial; 2022 Feb; 26(1):220-228. PubMed ID: 34057286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ABC of apheresis.
    Dierickx D; Macken E
    Acta Clin Belg; 2015 Apr; 70(2):95-9. PubMed ID: 25366579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Plasmapheresis: A Revision of Literature.
    Altobelli C; Anastasio P; Cerrone A; Signoriello E; Lus G; Pluvio C; Perna AF; Capasso G; Simeoni M; Capolongo G
    Kidney Blood Press Res; 2023; 48(1):66-78. PubMed ID: 36481657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological role of plasma and its components and the clinical implications of different methods of apheresis: A narrative review.
    Ahmadpoor P; Aglae C; Cariou S; Pambrun E; Renaud S; Garo F; Darmon R; Schultz C; Prelipcean C; Reboul P; Moranne O
    Ther Apher Dial; 2021 Jun; 25(3):262-272. PubMed ID: 32710797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The indication of steroid pulse therapy and apheresis therapy for multiple sclerosis].
    Ohji S; Nomura K
    Nihon Rinsho; 2008 Jun; 66(6):1127-32. PubMed ID: 18540358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired immunodeficiency syndrome (AIDS)--apheresis and operative risks.
    Kiprov DD; Lippert R; Sandstrom E; Jones FR; Cohen RJ; Abrams D; Busch DF
    J Clin Apher; 1985; 2(4):427-40. PubMed ID: 4066640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LDL-apheresis and immunoadsorption: novel methods in the treatment of renal diseases refractory to conventional therapy.
    Sułowicz W; Stompór T
    Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v59-62. PubMed ID: 12817074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurologic indications for therapeutic plasma exchange: an update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2011; 26(5):261-8. PubMed ID: 21915895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic plasma exchange and renal related vasculitis: therapeutic apheresis academy 2010.
    Balogun RA; Abdel-Rahman EM
    J Clin Apher; 2011; 26(5):291-6. PubMed ID: 21834080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic apheresis of immune diseases in nephrology department.
    Visvardis G; Manou E; Griveas I; Meimaridou D; Mitsopoulos E; Kyriklidou P; Papadopoulou D; Ginikopoulou E; Rottstein L; Sakellariou G
    Ren Fail; 2004 Sep; 26(5):569-74. PubMed ID: 15526917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double filtration plasmapheresis - 10-year pediatric experience as an alternative to plasma exchange.
    Maxted AP; Connell R; Hussain F
    Transfus Apher Sci; 2020 Dec; 59(6):102928. PubMed ID: 32919882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases.
    Masutani K; Katafuchi R; Ikeda H; Yamamoto H; Motoyama K; Sugitani A; Kanai H; Kumagai H; Hirakata H; Tanaka M; Iida M
    Clin Transplant; 2005; 19 Suppl 14():59-64. PubMed ID: 15955171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The selective therapeutic apheresis procedures.
    Sanchez AP; Cunard R; Ward DM
    J Clin Apher; 2013 Feb; 28(1):20-9. PubMed ID: 23420592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic apheresis in multiple sclerosis].
    Nomura K
    Nihon Rinsho; 2003 Aug; 61(8):1388-95. PubMed ID: 12962028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of low-density lipoprotein apheresis for nephrotic syndrome in a patient with immunoglobulin M nephropathy.
    Tanaka A; Nakamura T; Sato E; Node K
    Nephrology (Carlton); 2016 Dec; 21(12):1073-1074. PubMed ID: 27870230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.